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In both mouse and human, Notch1 activation is the main initial driver toinduce T-cell development in hematopoietic progenitor cells. The initia-tion of this developmental process coincides with Notch1-dependent
repression of differentiation towards other hematopoietic lineages.
Although well described in mice, the role of the individual Notch1 target
genes during these hematopoietic developmental choices is still unclear in
human, particularly for HES4 since no orthologous gene is present in the
mouse. Here, we investigated the functional capacity of the Notch1 target
genes HES1 and HES4 to modulate human Notch1-dependent hematopoi-
etic lineage decisions and their requirement during early T-cell develop-
ment. We show that both genes are upregulated in a Notch-dependent
manner during early T-cell development and that HES1 acts as a repressor
of differentiation by maintaining a quiescent stem cell signature in CD34+
hematopoietic progenitor cells. While HES4 can also inhibit natural killer
and myeloid cell development like HES1, it acts differently on the T- versus
B-cell lineage choice. Surprisingly, HES4 is incapable of repressing B-cell
development, the most sensitive hematopoietic lineage with respect to
Notch-mediated repression. In contrast to HES1, HES4 promotes initiation
of early T-cell development, but ectopic expression of HES4, or HES1 and
HES4 combined, is insufficient to induce T-lineage differentiation.
Importantly, knockdown of HES1 or HES4 significantly reduces human 
T-cell development. Overall, we show that the Notch1 target genes HES1
and HES4 have non-redundant roles during early human T-cell develop-
ment which may relate to differences in mediating Notch-dependent
human hematopoietic lineage decisions.
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ABSTRACT
Introduction
Multipotent hematopoietic stem cells (HSC) reside in the bone marrow after
birth and give rise to all the different blood cell types.1 This process is orchestrated
by integrating cell-intrinsic mechanisms and external stimuli which results in the
activation of molecular networks that drive differentiation towards specific
hematopoietic lineages.2,3 Such events are also important during the early stages of
intrathymic T-cell development. Following colonization of thymus-seeding 
progenitors from the bone marrow, Delta-like-ligand-4 (DLL4), which is expressed
by thymic epithelial cells, triggers the Notch1 receptor on these multipotent pre-
cursors. Activation of Notch1 induces T-cell differentiation through upregulation
of T-lineage genes and this also prevents differentiation towards other hematopoi-
etic lineages.4-6 In mice, the regulatory network that drives early T-cell development
has been well-studied. Activation of TCF1 contributes to the induction of T-lineage
genes,7 while Gata3 upregulation is important to impair B-lineage potential.8
Subsequently, residual natural killer (NK) cell potential is repressed by BCL11B that
completes T-cell commitment.9 During these steps, Notch activation remains
essential to guide the cells along the T-lineage differentia-
tion pathway and for proliferation and survival. In human,
however, the regulatory network that supports these
processes is less clear. Due to species-specific gene expres-
sion patterns and functions, extrapolation of murine data
is often not possible. One important difference between
human and mouse is the need for Notch signaling during
T-cell development. In both, strong Notch1 activation is
necessary to induce 
T-cell specification at the expense of B- and myeloid line-
age potential.10 In human, however, Notch signaling then
needs to be reduced for efficient differentiation towards
committed thymocytes,11 while in mouse high Notch
activity is maintained.12 Thereafter, Notch also differential-
ly modulates the differentiation towards T-cell receptor
(TCR)-αb and TCR-γd T-cells in mouse versus human.13-15
Activation of Notch1 results in the expression of many
different target genes whose individual roles in controlling
hematopoietic lineage decisions are still unclear. These
include some members of the HES gene family that
encode bHLH transcription factors that function as homo-
and heterodimers and repress their target genes through
recruitment of co-repressors.16 HES1 is a well-known tar-
get and is essential for the inhibition of myeloid develop-
ment during early T-lineage differentiation in mouse
through repression of C/EBP-α.17 It also plays a prominent
role in Notch-driven T-cell acute lymphoblastic leukemia
(T-ALL).18 Importantly, the human genome also encodes
HES4, a HES1 paralogue that is absent in the mouse19
(Online Supplementary Figure S1), but present in Xenopus
and Zebrafish. It has been documented that, depending on
the species, biological setting and tissue, HES4 can have
overlapping or antagonistic roles compared to HES1.20-24
Although HES4 displays clear Notch-dependent regula-
tion in Notch-driven cancers,25 it is unclear if HES4 can
mediate non-malignant Notch-driven hematopoietic line-
age decisions. 
Given that the individual roles of the various Notch tar-
get genes are still unclear, we studied the function of HES1
and HES4 during the early Notch-dependent hematopo-
ietic lineage decisions in human. We show that they have
both different and similar impacts on the differentiation of
human hematopoietic progenitor cells (HPC) towards 
various blood cell types when overexpressed, and that
both are essential during early human T-cell development.
Methods
Isolation of CD34+ hematopoietic precursor cells
Umbilical cord blood (CB) was obtained with informed consent
and used with approval of the Medical Ethical Commission of
Ghent University Hospital (Belgium). Mononuclear cells were iso-
lated through Lymphoprep density-gradient (ELITech) and CD34+
HPC were purified using CD34-magnetic beads (Miltenyi Biotec).
Other methods are available in the Online Supplementary
Material and Methods.  
Results
HES4, like HES1, displays Notch-dependent expression
and regulation during human T-lineage differentiation
HES4 was shown to be Notch dependent in leukemic T
cells,25 but whether HES4 displays Notch-dependent
expression during non-malignant T-cell development is
unclear. Gene expression analysis showed that both HES1
and HES4 are expressed during similar Notch-dependent
stages4,14 of human T-cell development (Figure 1A). This
Notch-dependent HES4 expression was functionally vali-
dated through exposure of CB CD34+Lin– HPC onto OP9
stromal cells that express different Notch ligands. HES1
and HES4 expression in HPC was only induced in condi-
tions that permit T-lineage differentiation (OP9-DLL1,
OP9-DLL4 and OP9-Jagged2 (JAG2)), but not in B-lineage
permissive conditions (OP9-GFP and OP9-JAG1; Figure
1B).26 Similarly, short 48 hour (h) co-culture experiments
onto OP9-GFP versus OP9-DLL1 stromal cells confirmed
the Notch-dependent expression of both HES genes in
intrathymic CD34+ cells, cells that have already experi-
enced in vivo Notch activation (Figure 1C). Publicly 
available data revealed that, in contrast to HES1, HES4 is
not expressed in HSC in the bone marrow (Online
Supplementary Figure S2A). However, HES4 expression is
detected in monocytes while lymphocytes and dendritic
cells (DC) express lower levels. Protein staining confirmed
the higher HES4 levels in monocytes compared to lym-
phocytes (Online Supplementary Figure S2B). These findings
illustrate that both HES1 and HES4 are Notch-dependent-
ly induced during human T-cell development. Given that
no information is available on the role of HES4 in human
hematopoiesis, we studied this using viral gene perturba-
tion approaches in human CD34+ HPC that are differenti-
ated towards various hematopoietic lineages in well-
established in vitro co-culture systems (Figure 1D).
HES4 lacks the potential to repress B-cell 
development
DLL4-dependent Notch1 activation is essential to
induce T-lineage differentiation at the expense of B-cell
development.6,13,27 Since both HES1 and HES4 are induced
following Notch1 activation, we investigated if these
genes have the potential to repress B-cell development
through enforced expression in CB HPC. This resulted in
50-fold higher expression levels of each gene compared to
ex vivo isolated CD34+ thymocytes that reflect physiologi-
cal Notch activation (Online Supplementary Figure S3A), and
protein staining suggests that slightly higher levels of
HES4 were obtained compared to HES1 (Online
Supplementary Figure S3B). HES1- and HES4-transduced
HPC were cultured on MS-5 stromal cells in B-lineage dif-
ferentiation conditions and compared to HPC transduced
with the constitutive active form of Notch1 (ICN1) that
mimics Notch activation and represses B-cell develop-
ment.13,27 Whereas control transduced HPC efficiently dif-
ferentiate into CD19+HLA-DR+ B-cells, enforced ICN1
expression inhibited B-cell development (Figure 2A-B).
Remarkably, while HES1 also inhibited B-lineage differen-
tiation, continuous HES4 expression did not impact B-cell
development (Figure 2A-B), and combined overexpression
of HES1 and HES4 showed a dominant repression of
HES1 (Online Supplementary Figure S4A-B). Consistently,
CD7+CD5+ T-cell precursors were generated in cultures
where ICN1 was overexpressed, but not within control
transduced conditions (Figure 2C-D). In contrast, enforced
expression of either HES1 or HES4 (Figure 2C-D), or HES1
and HES4 combined (Online Supplementary Figure S4C-D),
was insufficient to induce the development of CD7+CD5+
T-lineage progenitors. These findings show that HES1 and
HES4 have distinct capacities to mediate the Notch1-
HES1 and HES4 during T-cell development
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dependent T- versus B-cell lineage decision and that both
HES proteins, individually or combined, are insufficient to
impose T-cell fate.
HES4, but not HES1, promotes induction of T-lineage
differentiation 
To further study the impact of HES1 and HES4 on early
T-cell development, we performed perturbation experi-
ments in OP9-DLL4 co-cultures that support induction of
T-lineage differentiation in human HPC as illustrated
through the emergence of CD7+CD5+ T-cell precursors in
control transduced cells (Figure 3A). We analyzed these
cultures after 2 weeks to focus on the efficiency and kinet-
ics of induction of T-lineage specification and commit-
ment. Ectopic expression of ICN1 promoted the genera-
tion of early CD7+CD5+ and CD5+CD1a+ T-cell precursors
from HPC (Figure 3A, C) and yielded higher numbers of
these cells (Figure 3B, D). Enforced expression of HES1,
however, resulted in a significant reduction in the frequen-
cy and absolute number of CD7+CD5+ specified and
CD5+CD1a+ committed T-cells (Figure 3A-D). In contrast,
high levels of HES4 improved the differentiation of HPC
towards the T-cell lineage, although less efficient com-
pared to ICN1 overexpression (Figure 3A-D). This positive
role of HES4 on early T-lineage differentiation was coun-
teracted by HES1 when both were overexpressed (Online
Supplementary Figure S5A-B). Because previous work from
our lab demonstrated that JAG2, DLL1 and DLL4, but not
JAG1, have the potential to initiate T-cell development in
human HPC,26 we investigated if enforced HES4 expres-
sion could alter these Notch ligand requirements to induce
T-lineage differentiation. Whereas overexpression of
ICN1 in HPC was sufficient to induce T-cell development
in OP9-GFP, OP9-JAG1 and OP9-DLL4 co-cultures, HES4-
transduced cells, like the control, could only generate
CD7+CD5+ T-cell progenitors on OP9-DLL4 stromal cells
(Online Supplementary Figure S6A-D). Overall, these 
findings illustrate that, while continuous HES1 expression
inhibits T-lineage specification and commitment, HES4
can enhance induction of T-cell development in the pres-
ence of Notch signaling when present at higher levels
compared to endogenous HES1 expression. However,
HES4 is not sufficient to alter the Notch ligand require-
ments to induce T-lineage differentiation in HPC.
NK-cell development is severely hampered by HES1 and
HES4
In human, Notch1 activation is permissive for 
NK-lineage differentiation,28 and our laboratory previously
illustrated that this is mediated by the Notch1 target gene
DTX1.11 Here, we studied the impact of ectopic HES1 and
HES4 expression on NK-cell development through co-cul-
ture of control, ICN1-, HES1- and HES4-transduced HPC
on MS-5 stromal cells with cytokines supporting NK-cell
differentiation. As documented previously,28 enforced
ICN1 expression enhanced NK-cell development and
resulted in a significant increase in CD56+ NK-cells that
express CD7, a Notch-dependent marker during early 
T-cell development (Figure 4A, C). In contrast, both HES1
and HES4 reduced NK-cell development, and this was the
case for both CD56+CD7– and CD56+CD7+ subsets (Figure
4A-C). To investigate if HES4 overexpression can improve
the generation of CD56+CD7+ NK-cells in the presence of
Notch signaling, analogous to the Notch signaling require-
ment for HES4 to enhance differentiation towards CD7+
T-lineage precursors, we cultured control and HES4-trans-
duced HPC on MS5-DLL4 stromal cells in the presence of
NK-lineage supporting cytokines. However, also in these
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Figure 1. HES4, like HES1, is expressed Notch dependently during human T-cell differentiation. (A) Line plots show log2 normalized probe intensities for HES1 (black)
and HES4 (red) gene expression levels during normal T-cell development. Data shows the average expression of two independent experiments from two different
donors. Error bars indicate the standard error of the mean (SEM). (B) Quantitative RT-PCR of HES1 (black bars) and HES4 (red bars) in CB CD34+Lin– precursors cul-
tured for 3 days on OP9-GFP, OP9-DLL1, OP9-DLL4, OP9-JAG1 and OP9-JAG2. Data shows the average expression of four independent experiments, relative to the
mean of GAPDH and YHWAZ mRNA levels. Error bars indicate SEM. ***P<0.001; *P<0.05 (two-way ANOVA); ns: not significant. (C) DESeq2-normalized read counts
of HES1 (black bars) and HES4 (red bars) in thymic CD34+ cells cultured for 2 days on OP9-GFP and OP9-DLL1. Graphs show the average of two independent 




conditions, continuous HES4 expression impaired the
development of CD56+CD7+ NK-cells (Online
Supplementary Figure S7A-B). These findings illustrate that
both HES1 and HES4 can repress NK-cell development.
HES1 and HES4 inhibit the development of myeloid
cells
Notch1-mediated repression of myeloid lineage 
differentiation is critical following thymic colonization of
HPC4,6 and genetic experiments in mice revealed an impor-
tant role for HES1 in this process.17 To investigate if HES1
and HES4 can mediate repression of human myeloid
development downstream of Notch1, we cultured control,
ICN1-, HES1- and HES4-transduced HPC in conditions
that support myeloid differentiation. Consistent with ear-
lier work, enforced expression of ICN1 reduced myeloid
development.13,27,29 While this was mainly reflected by a
decrease in the absolute cell numbers for CD15+HLA-DR–
granulocytes and CD14+CD15– monocytes, for HLA-
DR+CD4+CD14–DC both the frequency and absolute cell
numbers were decreased (Figure 5A-D). In case of contin-
uous HES1 and HES4 expression, however, we observed a
reduction in both the percentage and absolute cell number
of granulocytes (Figure 5A-B) and monocytes (Figure 5A,
C). In contrast, while the absolute numbers of DC was
decreased by HES1 overexpression, this was not the case
upon ectopic expression of HES4. Furthermore, the fre-
quencies of DC were increased in these cultures (Figure
5A, D). Thus, both HES1 and HES4 have the potential to
repress monocyte and granulocyte differentiation down-
stream of Notch1, whereas DC development is less
impaired, consistent with the intrathymic development of
these antigen-presenting cells.
HES1, but not HES4, maintains a quiescent stem cell
signature in CD34+ cells
Enforced expression of HES1 can maintain a stem cell
signature in multiple cell types.16,30,31 To compare the effect
of HES1 and HES4 on HSC maintenance, we tracked the
frequency and number of CD34+ HPC, following ICN1,
HES1 or HES4 transduction, in OP9-DLL4 T-lineage 
differentiation conditions. In agreement with previous
studies,13,27 ectopic expression of ICN1 induced T-cell
development and resulted in a significant decrease in the
percentage and absolute number of CD34+ HPC (Figure
6A-C). Although conditions with elevated HES1 levels did
not yield higher numbers of CD34+ cells (Figure 6C), we
observed a significant and more than 2-fold increase in
their frequency (Figure 6A-B). In contrast, enforced
expression of HES4 did not affect the fraction of CD34+
HPC (Figure 6A-C). In addition, since earlier work illus-
trated that overexpression of HES1 results in the genera-
tion of quiescent HSC,18 we evaluated cellular prolifera-
tion. While HPC that express higher levels of HES1
displayed reduced proliferation, HES4-transduced cells
proliferated similarly as the control (Figure 6D). These 
findings suggest that HES1, but not HES4, can induce
maintenance of a quiescent stem cell state by repressing
differentiation and proliferation of CD34+ HPC.
RNA sequencing reveals HES1- and HES4-induced
molecular pathways during early human hematopoiesis
To reveal specific HES1- and HES4-induced molecular
changes, we performed RNA sequencing in control, HES1-
and HES4-transduced CD34+Lin– HPC that were cultured
in the absence or presence of Notch signaling on OP9-GFP
or OP9-DLL1, respectively. Enforced expression of HES1
in the absence of Notch1 activation (OP9-GFP, Notch-OFF,
Figure 7A) resulted in a significant downregulation of
genes associated with the differentiation of B-cells (MYB,32
GM2A,33 DUSP233 and IGLL134), NK-cells (ERI1,35 EMP336
and SRGN37) and myeloid cells (EPX,38 CLC,39 SRGN,37
MS4A240 and MS4A341) (Figure 7A). CEBPA expression was
not detected in these experiments. However, given the
essential role of HES1 in repression of CEBPA-dependent
myeloid differentiation in mouse,17 we evaluated the
HES1 and HES4 during T-cell development
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Figure 2. HES4 is not sufficient to inhibit B-cell development. Flow cytometric analysis (A, C) and absolute cell numbers (B, D) of control, ICN1-, HES1- and HES4-
transduced CD34+Lin– CB progenitors cultured on the MS-5 feeder (Notch-OFF) for 3 weeks in the presence of the B-lineage supporting cytokines IL-7 and SCF, show-
ing the development of CD19+HLA-DR+ B-lineage cells (A-B) and CD7+CD5+ T-lineage cells (C-D). Data shows the average of six independent experiments and error




impact of HES1 and HES4 on CEBPA expression in the
HL-60 leukemic cell line and, consistently, HES1 was very
potent in repressing CEBPA expression, while HES4 was
less efficient (Online Supplementary Figure S8A). In OP9-
DLL1-cultured CD34+ HPC (Notch-ON, Figure 7B), we
observed significant repression of Notch signaling and T-
lineage associated genes by HES1, including NOTCH1,
RBPJ, MYB42 and DAD143 (Figure 7B). Surprisingly, on
OP9-GFP stromal cells where no or little Notch1 trigger-
ing occurs, we also observed downregulation of these
genes upon HES1 overexpression (Figure 7C). Also IRF8
expression, which is induced by Notch signaling for DC
deve-lopment,44 was repressed by HES1 (Figure 7B). On
both OP9 stromal co-cultures, expression of IKZF1,
which is essential for differentiation of lymphoid-primed
multipotent progenitors into common lymphoid progen-
itors (CLP),45 was downregulated by high levels of HES1
(Figure 7A-B). In contrast, HES1 overexpression showed
significant upregulation of genes associated with stem
cell maintenance, such as CD34, CD44, HOXB246,
HOXB546, ESAM47 and ID148, and genes involved in cell
cycle arrest, including IGFBP4, CDKN2D and CDKN1C,
which was independent of Notch signaling (Figure 7A-B).
These findings were confirmed by gene set enrichment
analysis (GSEA) that revealed significant enrichment of
HSC markers and genes involved in CD34+ quiescence in
the HES1-transduced condition (Figure 7D-E). Genes 
associated with the maintenance of multipotent HSC at
the expense of both CLP and granulocyte-monocyte pro-
genitor (GMP) differentiation were also enriched upon
HES1 overexpression (Online Supplementary Figure S8B-
C). In contrast, HES4 overexpression did not result in
large gene expression changes. Among the significantly
downregulated genes, we found CLC and SRGN (Figure
7A, G), which were previously associated with respec-
tively myeloid and NK-cell development.37,39 Moreover,
upon HES4 overexpression, we observed a slight, but
non-significant upregulation of NOTCH1, RBPJ and
IKZF1 in the absence of Notch signaling (Figure 7C),
while this was not the case when the cells were cultured
on the OP9-DLL1 feeder (Figure 7B). Furthermore, high
levels of HES1 or HES4 resulted in a significant downreg-
ulation of HES1 itself (Figure 7F-G). Comparison of the
promotor sequences of the putative HES1 and HES4 tar-
get genes did not reveal a difference in the relative abun-
dance of E-box, N-box and C-site motifs between HES1
and HES4 targets (Online Supplementary Figure S9A).
However, using HOMER motif analysis, we observed a
difference in the top enriched transcription factor bind-
ing sites within HES1 and HES4 target gene promoters
(Online Supplementary Figure S9B-C). Thus, using RNA
sequencing, we identified potential downstream targets
of HES1 and HES4 that may modulate Notch-driven lin-
eage decisions during human hematopoiesis and this
may involve co-regulation by specific transcription fac-
tors.
HES1 and HES4 are both essential for inducing human
T-cell development in HPC
To investigate if HES1 and HES4 are required down-
stream of Notch during early human T-lineage differentia-
tion, we performed HES1 and HES4 short hairpin RNA
(shRNA)-mediated knockdown experiments in HPC that
were cultured on OP9-DLL4 in T-lineage supporting con-
ditions. For both genes, we used two independent shRNA
which induced 40-60% knockdown (Figure 8A).
Compared to the control, both the frequency and absolute
numbers of CD7+CD5+ T-lineage specified and
CD5+CD1a+ committed T-cell progenitors were signifi-
cantly reduced upon knockdown of either HES1 or HES4
(Figure 8B-E). However, we did not observe a diversion to
the B- or myeloid lineage in these cultures (data not shown),
probably as a result of insufficient knockdown.
Nevertheless, these findings illustrate that both HES1 and
M. De Decker et al.
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Figure 3. HES4, but not HES1, promotes induction of T-lineage differentiation. Flow cytometry analysis (A, C) and absolute cell numbers (B, D) of control, ICN1-,
HES1- and HES4-transduced CD34+ Lin- CB precursors cultured on the OP9-DLL4 feeder (Notch-ON) for 2 weeks in the presence of the T-lineage specific cytokines
IL-7, SCF and FLT3L, showing the development of CD7+ CD5+ (A-B) and CD5+ CD1a+ (C-D) T-lineage cells. Data shows the average of six independent experiments and




HES4 have essential and non-redundant roles during early
human T-cell development. 
Discussion
It is well established that Notch1 activation in thymus-
seeding precursors allows progenitor cells to differentiate
towards the T-cell lineage, while development towards
other hematopoietic cell types is repressed.4-6,13 However,
the individual roles of various Notch1 target genes during
these developmental choices are still unknown. Therefore,
we investigated the potential of HES1 and HES4 to mediate
human Notch1-dependent hematopoietic lineage decisions.
We illustrate that both genes are essential downstream of
Notch1 to induce human T-cell development and that they
have both similar and different potentials to repress the dif-
ferentiation towards alternative, non T-cell lineages. 
In murine hematopoiesis, HES1 is a repressor of
intrathymic myeloid differentiation during the Notch-
dependent induction of T-cell development.17 HES1 is also
required for sustaining leukemic growth in Notch-driven
T-ALL, both in mouse and human.18,49 Previous overex-
pression studies in human have shown that HES1 inhibits
B- and NK-lineage differentiation, but failed to reveal a
block in monocyte development.27 In agreement with pre-
vious work in mice,17 we show here that HES1 can repress
myeloid development in human and that this is mediated
through repression of several genes with known roles in
monocyte, granulocyte and dendritic cell development,
thereby providing novel molecular insights in this process.
The discrepancy in monocyte differentiation compared to
previous work27 may relate to differences in expression
levels following transduction since we used a codon-opti-
mized construct to facilitate comparison with HES4. This
could also explain the more efficient block in B-cell devel-
opment in our results.
Our novel RNA sequencing data reveal mechanisms
through which HES1 specifically represses T-, B- and NK-
associated genes, thereby validating the developmental
impacts in our co-cultures. In light of the requirement for
HES1 downstream of Notch1 during T-cell development,
the repression of T-lineage differentiation by HES1 is 
striking. While this may result from the high expression
levels in our perturbation settings, this may also reflect
stage-specific requirements for HES1 in this process that
are recurrent and may involve HES1 oscillation as
observed during embryonic development.16 Although it is
unclear if the latter occurs in developing thymocytes,
Notch activation is required at different stages of early 
T-cell development and recurrent Notch activation events
therein seem essential to balance between proliferation
and differentiation.4,50 While HES1 is required to repress
myeloid development in early T-cell precursors, it could
later be essential to maintain thymocytes in a quiescent
state, which is necessary during TCR rearrangements.4
Although less evident in human, this fits the high expres-
sion level of Hes1 in DN3a thymocytes that are active
TCR-rearranging cells.51 A role for HES1 as a regulator of
cell quiescence also concurs with the observation that con-
tinuous expression in HPC maintains cells in a CD34+ pre-
cursor state, consistent with previous studies.18,27 Here, we
show that this is correlated with the upregulation of genes
involved in stem cell maintenance, quiescence and cell
cycle arrest. However, while HES1 is dispensable in mice
for HSC maintenance,18 our data suggests that HES1
represses differentiation in human by maintaining a quies-
cent stem cell signature.
HES1 and HES4 during T-cell development
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Figure 4. HES1 and HES4 repress NK cell development. (A) Flow cytometric analysis of control, ICN1-, HES1- and HES4-transduced CB CD34+Lin– precursors cultured
on the MS-5 feeder (Notch-OFF) for 3  weeks in the presence of the NK-lineage specific cytokines IL-7, SCF, FLT3L and IL-15, showing the development of CD56+CD7-
and CD56+CD7+ NK cells. Plots shown are representative for six independent experiments. (B-C) Absolute numbers of CD56+CD7– (B) and CD56+CD7+ (C) NK cells
generated in corresponding cultures shown in (A). Data shows the average of six independent experiments. Error bars indicate the standard error of the mean (SEM).
*P<0.05 (non-parametric paired Wilcoxon test); ns: not significant. 
A
B C
For the first time, we study the role of HES4 as a down-
stream modulator of Notch during non-malignant human
hematopoiesis. In agreement with previous studies that
compared the function of HES1 and HES4 in brain and
bone development,20,21 our data suggests that both HES
proteins have similar, and also different roles during
human Notch-dependent hematopoietic lineage decisions.
Compared to HES1, which is a strong repressor with a
clear impact on HPC differentiation, enforced HES4
expression has a similar impact on myeloid and NK-cell
development, but not on B- and T-cell differentiation. We
believe that this lower repressive capacity of HES4 com-
pared to HES1 is not due to lower expression levels fol-
lowing transduction since we obtained a similar mRNA
increase for both HES genes, and protein staining even
suggested higher amounts of HES4 protein compared to
HES1.  These different repressive capacities may, howev-
er, reflect a more stringent role for HES genes in the
repression of myeloid fate compared to B-lineage differen-
tiation, which is in agreement with a genetic study in mice
that showed that intrathymic Notch signaling is more
important for the repression of myeloid development than
for preventing B-lineage diversion.52 One exception to the
robust repression of myeloid development by HES genes
concerns their impact on DC development. Although
HES1 overexpression did result in a significant reduction
in the absolute number of DC, their frequency was
increased compared to control transduced cells. Strikingly,
HES4 was not sufficient to robustly repress DC develop-
ment and this higher tolerance towards HES genes is in
agreement with the intrathymic and Notch-dependent
development of DC.53 Interestingly, in contrast to HES1,
HES4 did promote T-cell development in the presence of
Notch1 signaling. This places HES4 in line with other
Notch targets, such as IL7R and TCF7, that have clear
stimulating roles on T-cell development following Notch1
activation.11,54 However, HES4 by itself, or in combination
with HES1, is insufficient to induce T-cell development,26
indicating that other downstream targets, or combinations
thereof, are important for driving this process.
Nevertheless, the clear distinct roles of HES1 and HES4 on
B- and T-cell development may be important to control
the initial Notch-dependent B- versus T-cell lineage deci-
sion in which HES1 represses the B-cell lineage while
HES4 permits further T-cell development. Following this
initial bifurcation, both HES1 and HES4 may then be
required to repress NK-lineage differentiation while ini-
tially still permitting DC development. As such, HES1 and
HES4 may have unique roles during these early stages of
human T-cell differentiation, which are not-redundant as
illustrated through our loss-of-function studies.
Unfortunately, these knockdown studies did not result in
an increased development of other, non T-cell lineages,
but we believe this may result from the incomplete loss of
HES1 and HES4 expression in these experiments. 
In contrast to HES1, HES4 overexpression did not result
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Figure 5. Myeloid differentiation is hampered by HES1 and HES4. (A) Flow cytometry analysis of control, ICN1-, HES1- and HES4-transduced CB CD34+Lin- progeni-
tors cultured on the MS-5 feeder (Notch-OFF) for 1 week in the presence of the myeloid-lineage specific cytokines SCF, FLT3L, TPO, GM-CSF and G-CSF, showing the
development of CD15+HLA-DR– granulocytes (blue), CD14+CD15– monocytes (red) and HLA-DR+CD4+CD14– dendritic cells (green). t-SNE plots shown are representa-
tive of six independent experiments. (B-D) Absolute numbers of CD15+HLA-DR- granulocytes (B), CD14+CD15– monocytes (C) and HLA-DR+CD4+CD14– dendritic cells
(D) generated in corresponding cultures shown in (A). Data shows the average of six independent experiments and error bars indicate the standard error of the mean
(SEM). *P<0.05 (non-parametric paired Wilcoxon test); ns: not significant.
A
B C D
in large gene expression changes. This might reflect the
immature state of the transduced HPC since gene expres-
sion profiling was performed 48 h after transduction in an
effort to discover direct regulatory events. However, the
lack of HES4 expression in HSC suggests a minimal role
for this protein at this immature stage, and the precise
role for HES4 in gene regulation may therefore only be
revealed at later differentiation stages, such as following
Notch1 activation in immature thymocytes. Other
genome-wide approaches, such as ChIP-seq in 
HES4-expressing thymocytes, will be required to identify
other HES4 target genes. Remarkably, while we did not
observe clear differences in the relative abundance of spe-
cific HES binding motifs (E-box, N-box and C-site) in the
promotors of the predicted HES1 and HES4 target genes,
both HES proteins may differentially regulate downstream
target gene expression through interactions with other
transcription factors that are distinct for HES1 and HES4.
Such mechanism could explain their different impact on
hematopoietic lineage decisions. Intriguingly, we identified
HES1 as a downstream target of both HES1 and HES4,
thereby confirming the autoregulation of HES116 and sug-
gesting a novel feedback loop between HES4 and HES1
that may also contribute to a possible transient repression
of HES1, thereby allowing early thymocytes to escape
from the repressive effects of HES1 to support their further
differentiation. Such a direct repressive role of HES4 on
HES1 expression seems essential given that protein inter-
actions through the formation of HES1-HES4 heterodimers
seemingly fail to counteract the strong repressive activity
of HES1 homodimers. We anticipate that single cell
(sc)RNA sequencing will provide more detailed insights
into the actual sequence of HES1 and HES4 expression dur-
ing early human T-cell development. 
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Figure 6. HES1, but not HES4, induces stem cell maintenance and quiescence in CD34+ cells. (A) Flow cytometric analysis of control, ICN1-, HES1- and HES4-trans-
duced CB CD34+Lin– precursors cultured on the OP9-DLL4 feeder for 2 weeks in the presence of the T-lineage specific cytokines IL-7, SCF and FLT3L, showing the
maintenance of CD34+ HPC. Plots shown are representative of six independent experiments. (B-C) Frequency (B) and absolute numbers (C) of CD34+ cells maintained
in corresponding cultures shown in (A). Data shows the average of six independent experiments. Error bars indicate the standard error of the mean (SEM). *P<0.05
(non-parametric paired Wilcoxon test); ns: not significant. (D) Flow cytometry analysis of control (grey), HES1 (black)- and HES4 (red)-transduced CB CD34+Lin– HPC
cultured on the OP9-DLL4 feeder for 2 weeks in the presence of the T-lineage supporting cytokines IL-7, SCF and FLT3L, showing proliferation as measured by the
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Figure 7 (previous page). Gene expression analysis of HES1 and HES4 during human hematopoiesis. (A) Heat map representation of differentially expressed genes
in control versus HES1-, or HES4-transduced CB CD34+Lin– cells cultured for 1 day on OP9-GFP (Notch-OFF), highlighting genes involved in the differentiation towards
the B-, natural killer (NK)- and myeloid lineage (top) and HSC maintenance and quiescence (bottom). (B) Heat map representation of differentially expressed genes
in control versus HES1-, or HES4-transduced CB CD34+Lin– progenitors cultured for 1 day on OP9-DLL1 (Notch-ON), highlighting genes involved in the 
differentiation towards the T-lineage (top) and HSC maintenance and quiescence (bottom). (C) Heat map representation of differentially expressed genes in control
versus HES1-, or HES4-transduced CB CD34+Lin– cells cultured for 1 day on OP9-GFP (Notch-OFF), highlighting genes associated with Notch signaling and T-cell devel-
opment. (D-E) GSEA shows a significant enrichment of HSC markers (D) and genes involved in quiescence (E) in the HES1-transduced condition compared to control.
(F-G) Volcano plot representation of control versus HES1 (F)-, or HES4 (G)-transduced CB CD34+Lin– precursors cultured for 1 day on OP9-GFP, highlighting the expres-
sion of the top 10 differentially expressed genes. Red dots indicate significance (padj<0.05; n=3).
Figure 8. Non-redundant roles for HES1 and HES4 during early human T-cell development. (A) Quantitative RT-PCR of HES1 (black bars) and HES4 (red bars) in CB
CD34+Lin– cells transduced with a control or two different HES1 or two different HES4 single hairpin RNA (shRNA), respectively, and cultured for 3 days on OP9-DLL4
to induce Notch activation. Data shows the average expression of four independent experiments, relative to the mean of ACTB and GAPDH mRNA levels, and nor-
malized to expression in the control shRNA condition. Error bars indicate the standard error of the mean (SEM). **P<0.01; *P<0.05 (paired Student’s t-test). (B-C)
Flow cytometry analysis of control, HES1 and HES4 shRNA-transduced CD34+Lin– hematopoietic progenitor cells (HPC) cultured on the OP9-DLL4 stromal cells for 2
weeks in the presence of the T-lineage supporting cytokines IL-7, SCF and FLT3L, showing the development of CD7+CD5+ (B) and CD5+CD1a+ (C) T-cell precursors.
Contour plots shown are representative for six independent experiments. (D-E) Absolute numbers of CD7+CD5+ T-lineage specified (D) and CD5+CD1a+ T-lineage com-
mitted (E) progenitors generated in corresponding cultures shown in (B) and (C), respectively. Data shows the average of six independent experiments and error bars





Given that HES4 is not present in the mouse genome, this
work thus improves our understanding of the mechanisms
through which Notch activation controls human blood cell
development. This is an important issue since we have pre-
viously documented that Notch activation has different
impacts on T-cell development in human versus mouse.4,14,55
Our work shows that both HES1 and HES4 are important
to support the Notch1-dependent induction of human T-
cell development and that this may be regulated through
both different and similar repressive mechanism on other
hematopoietic lineages. These findings thus underscore the
distinct regulatory functions of each member of the com-
plex network of Notch1 downstream target genes. 
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